Trial Profile
A Phase 2, Dose-Finding, Cross-Over Study to Evaluate the Effect of a NES/E2 Transdermal Gel Delivery on Ovulation Suppression in Normal Ovulating Women
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Estradiol/elcometrine (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- 16 Apr 2015 Planned End Date changed from 1 Jun 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov record.
- 16 Apr 2015 Planned primary completion date changed from 1 Jun 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov record.
- 16 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.